Nanoplatforms for Targeted Molecular Imaging in Living Subjects

Molecular or personalized medicine is the future of patient management and molecular imaging plays a key role towards this goal. Recently, nanoplatform‐based molecular imaging has emerged as an interdisciplinary field, which involves chemistry, engineering, biology, and medicine. Possessing unpreced...

Full description

Saved in:
Bibliographic Details
Published inSmall (Weinheim an der Bergstrasse, Germany) Vol. 3; no. 11; pp. 1840 - 1854
Main Authors Cai, Weibo, Chen, Xiaoyuan
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 05.11.2007
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Molecular or personalized medicine is the future of patient management and molecular imaging plays a key role towards this goal. Recently, nanoplatform‐based molecular imaging has emerged as an interdisciplinary field, which involves chemistry, engineering, biology, and medicine. Possessing unprecedented potential for early detection, accurate diagnosis, and personalized treatment of diseases, nanoplatforms have been employed in every single biomedical imaging modality, namely, optical imaging, computed tomography, ultrasound, magnetic resonance imaging, single‐photon‐emission computed tomography, and positron emission tomography. Multifunctionality is the key advantage of nanoplatforms over traditional approaches. Targeting ligands, imaging labels, therapeutic drugs, and many other agents can all be integrated into the nanoplatform to allow for targeted molecular imaging and molecular therapy by encompassing many biological and biophysical barriers. In this Review, we will summarize the current state‐of‐the‐art of nanoplatforms for targeted molecular imaging in living subjects. A view on imaging: Many nanoparticles and a variety of techniques have been used for targeted molecular imaging in living subjects. This Review article takes an overview of the various materials and techniques that are currently at the development stage, undergoing clinical trials, or are even in current usage. The image shows how tumors in mice can be highlighted with quantum dots using near‐infrared fluorescence imaging.
Bibliography:ark:/67375/WNG-P00KD8FT-D
istex:2F3DAE5E5588648E4851EBC5FA698AF9C432BBA8
ArticleID:SMLL200700351
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
ISSN:1613-6810
1613-6829
1613-6829
DOI:10.1002/smll.200700351